National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

benzoylphenylurea
A low molecular weight agent with antineoplastic activity. Benzoylphenylurea binds to the colchicine binding site on tubulin, thereby blocking tubulin polymerization and disrupting mitotic function. This agent also inhibits DNA polymerase, and has been shown to arrest leukemia cells in the G1-S transition phase of the cell cycle. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:BPU



Previous:Bendopa, Benefin, Benemid, Beneo Synergy 1, Benoquin
Next:benzydamine hydrochloride, berubicin hydrochloride, beta carotene, beta-glucan, beta-lapachone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov